Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Rosetta Expands Lab in Israel

July 23, 2007 | A version of this story appeared in Volume 85, Issue 30

Rosetta Genomics has expanded its Israeli research facility to support its microRNA-based diagnostic program. The new lab space will enable the company to advance its microRNA-based diagnostic products in oncology, and create room to increase its staff from about 50 people to 70 by the end of the year. Rosetta, which claims to be the only firm solely focused on microRNA, is tapping into the power of small RNA to regulate gene expression for diagnostics and therapeutics across a range of diseases.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.